- US12612630utility2026Compositions and Methods for Splicing Modulation of UNC13A0 cites
- USD1122941design2026Display Screen with Graphical User Interface0 cites
- US12599715utility2026Syringe Stabilizer0 cites
- US12590157utility2026Methods of Treating Gastrointestinal Immune-related Adverse Events in Immune Oncology Treatments0 cites
- US12582714utility2026Methods and Compositions for Freezing and Thawing Mammalian Cells0 cites
- USD1118916design2026Particle Prevention Adapter0 cites
- USD1115796design2026Display Screen or Portion Thereof with Graphical User Interface0 cites
- US12559465utility2026Substituted Benzotriazinone Metabolites of a GPR139 Agonist0 cites
- US12553842utility2026Determination of Modification Degree of Therapeutic Proteins Using 1H-NMR Spectroscopy0 cites
- US12553050utility2026Compositions and Methods for Inhibiting Cytochrome P450 Family 7 Subfamily a Member 1 (CYP7A1) Expression0 cites
- US12553062utility2026AAV Compositions0 cites
- US12551561utility2026Nucleic Acid-containing Lipid Nano-particle and Use Thereof0 cites
- US12545931utility2026Method for Transfection Into Cardiomyocytes Using Cationic Lipid0 cites
- US12544445utility2026Methods for Treatment Using Anti-α4β7 Antibody0 cites
- US12545703utility2026Method to Produce an Immunoglobulin Preparation with Improved Yield0 cites
- US12534471utility2026Pyrrolo[1, 2-c]imidazole Derivatives as Orexin Type 2 Receptor Agonists and Methods of Use Thereof0 cites
- US12528880utility2026Plasma Kallikrein Inhibitors and Uses Thereof for Treating Pediatric Hereditary Angioedema Attack0 cites
- US12527771utility2026Viral Inhibitors, the Synthesis Thereof, and Intermediates Thereto0 cites
Page 1 of 13Next →